COCO insider disposes 20,000 shares; holds large $10.18 options
Rhea-AI Filing Summary
Vita Coco Company, Inc. (COCO) reported insider sales by Martin Roper executed under a Rule 10b5-1 trading plan. The filing shows multiple dispositions of 5,000 shares on 10/03/2025 and 10/06/2025, with reported weighted-average prices around $42.6–$42.9. After the reported sales, Mr. Roper directly beneficially owned 293,897 shares and held indirect interests through family trusts and related parties; several family trusts show remaining indirect holdings in the low- to mid-200,000s.
The form also lists fully vested and exercisable non-qualified stock options and other option grants: a large exercisable option for 579,670 shares at an exercise price of $10.178, plus additional option tranches totaling several hundred thousand shares with exercise prices from $10.178 to $32.78 and various vesting/expiration dates through 2035. The sales were made pursuant to a 10b5-1 plan; the filer offered to provide transaction-level price details on request.
Positive
- Sales executed under a Rule 10b5-1 plan providing pre-established trading parameters
- Reporting person retains significant vested options (e.g., 579,670 shares exercisable at $10.178) indicating ongoing alignment with equity performance
- Willingness to disclose weighted-average price ranges and to provide transaction-level details on request
Negative
- Insider sold a total of 20,000 shares over two dates, which modestly reduces direct holdings
- Large option positions could lead to future dilution if exercised and shares are sold into the market
Insights
Insider sold modest stakes under a 10b5-1 plan while retaining large option positions.
The sales reported total 20,000 common shares across 10/03/2025 and 10/06/2025 at weighted-average prices near $42.6–$42.9, executed under a Rule 10b5-1 plan which provides an affirmative defense to insider trading claims when conditions are met. The reporting shows both direct holdings and material indirect holdings through family trusts, preserving substantial economic exposure to company equity.
Remaining option positions are sizable: a fully exercisable option for 579,670 shares at $10.178 plus additional grants summing to several hundred thousand shares with exercise prices up to $32.78 and expirations through 2035. Monitor any future scheduled exercise or sale activity and filings that change outstanding option or trust holdings over the next 12–24 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $42.671 | $213K |
| Sale | Common Stock | 5,000 | $42.618 | $213K |
| Sale | Common Stock | 5,000 | $42.60 | $213K |
| Sale | Common Stock | 5,000 | $42.51 | $213K |
| Sale | Common Stock | 5,000 | $42.918 | $215K |
| Sale | Common Stock | 5,000 | $42.911 | $215K |
| Sale | Common Stock | 5,000 | $42.914 | $215K |
| Sale | Common Stock | 5,000 | $42.917 | $215K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.11, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.90 to $43.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Christopher G. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.92 to $43.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Peter S. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.92 to $43.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.52 to $43.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Thomas L. Roper Exempt Family Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.90 to $43.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
